1 |
Scully C, Oral and maxillofacial medicine. 1st ed., Wright, 2004, Elsevier, pp.252-268
|
2 |
Blomgren J, Berggren U, Jontell M. Fluconazole versus nystatin in the treatment of oral candidosis. Acta Odontol Scand 1998;56:202-205
DOI
|
3 |
Mycek MJ, Harvey RA, Champe PC. Lippincott's illustrated reviews : pharmacology. 2nd ed., Hampton, 2000, Lippincott Williams & Wilkins, pp.337-344
|
4 |
Francois IE, Aerts AM, Cammue BP, Thevissen K. Currently used antimycotics: spectrum, mode of action and resistance occurrence. Curr Drug Targets 2005;6:895-907
DOI
ScienceOn
|
5 |
Ellepola AN, Samaranayake LP. Oral candidal infections and antimycotics. Crit Rev Oral Biol Med 2000;11:172-198
DOI
|
6 |
Neville BW, Damm DD, Allen CM, Bouquot JE. Oral & maxillofacial pathology. 2nd ed., Philadelphia, 2002, WB Saunders Co., pp.189-197
|
7 |
Force RW, Nahata MC. Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis. Ann Pharmacother 1995;29:10-15
DOI
|
8 |
McCullough MJ, Savage NW. Oral candidosis and the therapeutic use of antifungal agents in dentistry. Aust Dent J 2005;50:S36-39
DOI
ScienceOn
|
9 |
Darwazeh AMG, Lamey PJ, Lewis MAO, Samaranayake LP. Systemic fluconazole therapy and in vitro adhesion of Candida albicans to human buccal epithelial cells, J Oral Pathol Med 1991;20:17-19
DOI
ScienceOn
|
10 |
Shin ES, Chung SC, Kim YK, Lee SW, Kho HS. The relationship between oral Candida carriage and the secretor status of blood group antigens in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:48-53
DOI
ScienceOn
|
11 |
Samaranayake LP, Ferguson MM. Delivery of antifungal agents to the oral cavity. Adv Drug Deliv Rev 1994;13:161-179
DOI
ScienceOn
|